Ignite Creation Date:
2024-05-06 @ 3:26 PM
Last Modification Date:
2024-10-26 @ 1:49 PM
Study NCT ID:
NCT04633915
Status:
COMPLETED
Last Update Posted:
2021-08-03
First Post:
2020-11-15
Brief Title:
Antibody Response in Hemodialysis and Non-dialysis Patients Diagnosed With COVID-19
Sponsor:
Saint Petersburg State University Russia
Organization:
Saint Petersburg State University Russia
Study Overview
Official Title:
A Comparison of Antibody Response Against SARS-CoV-2 in Hemodialysis and Non-dialysis Patients Diagnosed With COVID-19
Status:
COMPLETED
Status Verified Date:
2021-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
COV-HD
Brief Summary:
This is prospective cohort study aimed to compare antibody response against SARS-CoV-2 in dialysis patients and non-dialysis-dependent volunteers
The research hypothesis is that dynamic of IgG antibodies against SARS-CoV-2 will differ in two groups
To determine whether there is a statistically significant interaction between factors group and time on the titer of IgG antibodies against SARS-CoV-2 a two-way repeated measures ANOVA will be used
The research hypothesis is that dynamic of IgG antibodies against SARS-CoV-2 will differ in two groups
To determine whether there is a statistically significant interaction between factors group and time on the titer of IgG antibodies against SARS-CoV-2 a two-way repeated measures ANOVA will be used
Detailed Description:
In both groups level of IgG antibodies against SARS-CoV-2 will be measured at the Day 1 10 weeks from the date of first symptoms Weeks 8 and 16 from the Day 1
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None